how to know when a re-biopsy is necessary for an advanced nsclc patient?
Published 5 years ago • 777 plays • Length 6:01Download video MP4
Download video MP3
Similar videos
-
10:09
esmo 2020 expert video report on long term ici outcomes in lung cancer
-
1:38
practical considerations for molecular profiling in nsclc
-
1:20:16
optimizing advanced nsclc biomarker testing, treatment and management session 1
-
3:34
repeat biopsy in lung cancer patients with egfr mutation
-
5:18
expert video report on amivantamab in combination therapy for 1l treatment in egfrm, advanced nsclc
-
1:39:03
everything you need to know about biomarker testing and treatment of genomically altered nsclc
-
1:24:39
optimizing advanced nsclc biomarker testing, treatment and management session 3
-
2:33
repeat biopsies in lung cancer - how important are they?
-
7:00
expert report on neoadjuvant immune checkpoint inhibitors for nsclc
-
16:24
patient selection for focal therapy: what is an optimal biopsy strategy?
-
6:40
ablation of lung cancer
-
4:31
expert video report on combination treatments in first-line oncogene addicted advanced nsclc
-
1:14:14
fine-tuning biomarker testing to identify and target ret fusions in nsclc
-
1:24:29
optimizing advanced nsclc biomarker testing, treatment and management session 2
-
2:25
gracecastuc-075_lung_recommending a repeat biopsy with acqd. resistance to targeted therapy
-
36:48
personalized therapy for nsclc: biomarker testing, treatment & management in met alterations
-
52:01
ascp project echo® videoconference series: best practices in advanced nsclc specimen management
-
1:07:31
precision decisions in genomic testing and targeted treatment of nsclc
-
9:39
how are we using liquid biopsy in nsclc?